타우린의 생산방법

시스테산의 생체변환으로부터 타우린의 몰 수율이 바람직하게는 60% 이상인 것을 특징으로 하는 방법. The invention relates to a process for producing taurine from O-acetyl-L-serine (OAS) by way of biotransformation. In a first process step (biotransformation 1), L-cysteic acid is produced from O-acetyl-L-serine (OAS) using an enzyme selected f...

Full description

Saved in:
Bibliographic Details
Main Authors PFALLER RUPERT, WICH GUENTER
Format Patent
LanguageKorean
Published 21.06.2024
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:시스테산의 생체변환으로부터 타우린의 몰 수율이 바람직하게는 60% 이상인 것을 특징으로 하는 방법. The invention relates to a process for producing taurine from O-acetyl-L-serine (OAS) by way of biotransformation. In a first process step (biotransformation 1), L-cysteic acid is produced from O-acetyl-L-serine (OAS) using an enzyme selected from the group of OAS sulfhydrylases (EC 4.2.99.8) in the presence of a sulfurous acid salt and subsequently, in a second process step (biotransformation 2), L-cysteic acid is decarboxylated to form taurine. This type of biotransformation provides taurine.
Bibliography:Application Number: KR20247018113